Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China · Delayed Price · Currency is CNY 4.130
-0.040 (-0.96%)
Oct 28, 2026, 11:29 AM CST
SHA:600572 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,828 | 6,473 | 6,515 | 6,733 | 6,000 | 6,568 |
Revenue Growth | 3.80% | -0.64% | -3.23% | 12.21% | -8.64% | 11.15% |
Gross Profit Gross Profit Growth | 3,740 | 3,422 | 3,414 | 3,897 | 3,531 | 3,942 |
Operating Income Operating Income Growth | 754.62 | 529.22 | 580.51 | 804.32 | 690.41 | 674.18 |
Net Income Net Income Growth | 456.74 | 474.36 | 622.42 | 591.57 | 358.12 | 2,017 |
Earnings Per Share EPS Growth | 0.18 | 0.19 | 0.25 | 0.23 | 0.14 | 0.78 |
EPS Growth | -34.48% | -24.00% | 8.70% | 64.29% | -82.05% | 333.33% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Manufacturing Industry Manufacturing Industry Growth | 5,576 |
Business Business Growth | 806.37 |
Total Total Growth | 6,382 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 882.42 | 1,674 | 1,322 | 2,570 | 2,468 | 2,573 |
Total Debt Total Debt Growth | 189.57 | 303.7 | 423.77 | 1,238 | 1,197 | 1,492 |
Net Cash (Debt) Net Cash Growth | 692.85 | 1,370 | 898.34 | 1,332 | 1,271 | 1,082 |
Net Cash Growth | 59.61% | 52.51% | -32.57% | 4.81% | 17.53% | - |
Net Cash Per Share Net Cash Per Share Growth | 0.28 | 0.55 | 0.36 | 0.52 | 0.50 | 0.42 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,231 | 942.61 | 1,013 | 898.64 | 1,155 | 891.23 |
Capital Expenditures CapEx Growth | -224.28 | -147.26 | -290.63 | -209.14 | -291.75 | -581.42 |
Free Cash Flow Free Cash Flow Growth | 1,007 | 795.35 | 721.9 | 689.5 | 863.73 | 309.8 |
Free Cash Flow Growth | 16.89% | 10.17% | 4.70% | -20.17% | 178.80% | -60.75% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 54.78% | 52.87% | 52.41% | 57.88% | 58.84% | 60.02% |
Operating Margin | 11.05% | 8.18% | 8.91% | 11.95% | 11.51% | 10.26% |
Pretax Margin | 9.50% | 9.97% | 11.97% | 11.40% | 9.83% | 38.47% |
Profit Margin | 6.69% | 7.33% | 9.55% | 8.79% | 5.97% | 30.72% |
FCF Margin | 14.75% | 12.29% | 11.08% | 10.24% | 14.39% | 4.72% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.150 | 0.150 | 0.150 | 0.200 | 0.150 | 0.160 |
Dividend Per Share Growth | 0% | 0% | -25.00% | 33.33% | -6.25% | - |
Dividend Yield | 3.63% | 3.36% | 3.23% | 3.96% | 3.17% | 3.20% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.73 | 23.83 | 18.77 | 21.94 | 33.95 | 6.37 |
Forward PE | - | 14.80 | 15.53 | 16.16 | 15.92 | 15.92 |
P/FCF Ratio | 10.51 | 14.21 | 16.18 | 18.82 | 14.07 | 41.48 |
PS Ratio | 1.55 | 1.75 | 1.79 | 1.93 | 2.03 | 1.96 |